Key Takeaways
- In the United States, approximately 244,000 children and adolescents younger than 20 years have diagnosed diabetes, with type 1 diabetes accounting for the majority at around 208,000 cases as of 2022
- Globally, around 1.2 million children and adolescents aged 0-19 years are living with type 1 diabetes as of 2021, representing a 24% increase from 2017
- In Europe, the incidence of type 1 diabetes in children under 15 years has risen by 3-4% annually over the past two decades, reaching 15-20 new cases per 100,000 children in 2020
- Family history of type 1 diabetes increases risk by 15-fold if a sibling is affected and 5-fold if a parent
- Genetic susceptibility via HLA-DR/DQ genes accounts for 40-50% of type 1 diabetes risk in children
- Early exposure to cow's milk protein before 3 months raises type 1 diabetes risk by 1.5-2 times in genetically susceptible infants
- The classic symptom of polydipsia affects 97% of children at type 1 diabetes diagnosis
- Polyuria is reported in 85-95% of newly diagnosed type 1 diabetic children under 10 years
- Unexplained weight loss occurs in 80% of pediatric type 1 diabetes cases at presentation
- Insulin pump initiation within 1 week of diagnosis reduces honeymoon phase loss by 20%
- Basal-bolus insulin regimens achieve A1C <7.5% in 55% of children with type 1 diabetes after 1 year
- Metformin monotherapy controls type 2 diabetes in 60% of obese youth for first 2 years
- Nephropathy develops in 20-30% of type 1 children with A1C >9% for >5 years untreated early
- Retinopathy prevalence 17% in type 1 adolescents with 5+ years duration and poor control
- CVD mortality 10-fold higher in adults diagnosed with type 1 diabetes in childhood vs general pop
Type 1 diabetes continues to increase in children worldwide, with rates rising across many countries through 2026.
Complications and Outcomes
Complications and Outcomes Interpretation
Prevalence and Incidence
Prevalence and Incidence Interpretation
Risk Factors and Causes
Risk Factors and Causes Interpretation
Symptoms and Diagnosis
Symptoms and Diagnosis Interpretation
Treatment and Management
Treatment and Management Interpretation
Sources & References
- Reference 1CDCcdc.govVisit source
- Reference 2IDFidf.orgVisit source
- Reference 3NCBIncbi.nlm.nih.govVisit source
- Reference 4DIABETESAUSTRALIAdiabetesaustralia.com.auVisit source
- Reference 5DIABETESdiabetes.org.ukVisit source
- Reference 6DIABETESdiabetes.caVisit source
- Reference 7PUBMEDpubmed.ncbi.nlm.nih.govVisit source
- Reference 8SCIELOscielo.brVisit source
- Reference 9DMSJOURNALdmsjournal.biomedcentral.comVisit source
- Reference 10SADSAsadsa.org.zaVisit source
- Reference 11HEALTHhealth.govt.nzVisit source
- Reference 12DVNdvn.nlVisit source
- Reference 13TIDtid.nibroc.noVisit source
- Reference 14TURKDIABturkdiab.orgVisit source
- Reference 15PDRApdra.org.phVisit source
- Reference 16DIABETESdiabetes.orgVisit source
- Reference 17NEJMnejm.orgVisit source
- Reference 18NATUREnature.comVisit source
- Reference 19NHSnhs.ukVisit source
- Reference 20CAREcare.diabetesjournals.orgVisit source






